⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALXO News
ALX Oncology Holdings Inc. Common Stock
Form 8-K
sec.gov
ALXO
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
globenewswire.com
ALXO
ALX Oncology to Present at Upcoming Investor Conferences in September
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ALXO
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ALXO
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
globenewswire.com
ALXO
Form 8-K
sec.gov
ALXO